FDA Adverse Event
Injury
Summary report: N
EUFLEXXA 1% SOLUTION FOR INJECTION 10MG/1ML
MDR report key: 10005044
·
Received April 27, 2020
Report
- Report Number
- MW5094287
- Event Type
- Injury
- Date Received
- April 27, 2020
- Date of Event
- April 24, 2020
- Report Date
- April 24, 2020
- Manufacturer
- BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. C/O FERRING PHARMACEUTICALS INC.
- Product Code
- MOZ
- UDI-DI
- 55566410001
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- NURSE
Narratives
Description of Event or Problem · 1
EUFLEXXA WILL BE INJECTED INTO THE RIGHT SHOULDER. IT IS INDICATED FOR THE KNEE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 467228 | EUFLEXXA 1% SOLUTION FOR INJECTION 10MG/1ML | ACID, HYALURONIC, INTRAARTICULAR | MOZ | BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. C/O FERRING PHARMACEUTICALS INC. | 55566410001 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 54 YR |